€13.28
3.63% today
Brüssel, Nov 26, 11:54 am CET
ISIN
BE0003766806
Symbol
IBAB
Sector

Ion Beam Applications Stock price

€13.78
-0.20 1.43% 1M
-0.22 1.57% 6M
+2.24 19.41% YTD
+2.66 23.92% 1Y
-1.30 8.62% 3Y
+0.02 0.15% 5Y
-0.45 3.16% 10Y
Brüssel, Closing price Mon, Nov 25 2024
+0.04 0.29%
ISIN
BE0003766806
Symbol
IBAB
Sector

Key metrics

Market capitalization €402.30m
Enterprise Value €401.95m
P/E (TTM) P/E ratio 51.06
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.86
P/S ratio (TTM) P/S ratio 0.86
P/B ratio (TTM) P/B ratio 4.46
Dividend yield 1.23%
Last dividend (FY23) €0.17
Revenue growth (TTM) Revenue growth 25.66%
Revenue (TTM) Revenue €465.75m
EBIT (operating result TTM) EBIT €26.76m
Free Cash Flow (TTM) Free Cash Flow €-31.57m
EPS (TTM) EPS €0.27
P/E forward 38.28
P/S forward 0.86
EV/Sales forward 0.86
Show more

Is Ion Beam Applications a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Ion Beam Applications Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Ion Beam Applications forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Ion Beam Applications forecast:

Buy
67%
Hold
33%

Financial data from Ion Beam Applications

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
466 466
26% 26%
100%
- Direct Costs 307 307
17% 17%
66%
159 159
46% 46%
34%
- Selling and Administrative Expenses 70 70
7% 7%
15%
- Research and Development Expense 51 51
10% 10%
11%
39 39
1,521% 1,521%
8%
- Depreciation and Amortization 12 12
6% 6%
3%
EBIT (Operating Income) EBIT 27 27
294% 294%
6%
Net Profit 7.85 7.85
140% 140%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Ion Beam Applications directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. It operates through the Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment include development, fabrication, and services associated with medical and industrial particle accelerators and proton therapy systems. The Dosimetry segment comprises activities that offer a full range of solutions and services that maximize efficiency and minimize errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company was founded by Yves Jongen on March 28, 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Head office Belgium
CEO Olivier Legrain
Employees 1,986
Founded 1986
Website www.iba-worldwide.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today